Results 91 to 100 of about 636,626 (282)
Advanced NanoBiomed Research, Volume 5, Issue 12, December 2025.Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez +3 more
wiley +1 more source
Food Bioengineering, Volume 4, Issue 4, Page 589-611, December 2025.ABSTRACT Artificial intelligence (AI) has emerged as a paradigm‐shifting force in enzyme engineering, enabling data‐driven prediction of catalytic activity, stability, and substrate specificity. By integrating large‐scale datasets from structured databases (e.g., PDB, BRENDA) and high‐throughput experimentation (e.g., deep mutational scanning ...
Xiafeng Lu +11 more
wiley +1 more source
Epidemic size, duration and vaccine stockpiling following a large-scale attack with smallpox
Global Biosecurity, 2019 On August 16th, 2018, we held Exercise Mataika to test preparedness for a worst-case scenario of a smallpox attack which begins in the Pacific and is followed by a larger scale attack in a highly populous Asian country.
C. R. MacIntyre +5 more
semanticscholar +1 more source
Health Science Reports, Volume 8, Issue 12, December 2025.ABSTRACT Background and Aims The recent emergence and rapid spread of monkeypox (Mpox) have become a global public health concern. Gaps in proper information dissemination can cause confusion and knowledge divergence among the general public, leading to difficulties in disease management.
Radwan Raquib +8 more
wiley +1 more source
Open Forum Infectious Diseases, 2015 Background First- and second-generation smallpox vaccines are contraindicated in individuals infected with human immunodeficiency virus (HIV). A new smallpox vaccine is needed to protect this population in the context of biodefense preparedness.
E. Overton +18 more
semanticscholar +1 more source
Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re‐emergence
Health Science Reports, Volume 8, Issue 12, December 2025.ABSTRACT Introduction Re‐emerging infectious diseases pose significant public health challenges in Africa and demand robust and coordinated responses. The Mpox virus (MPXV) has increasingly caused outbreaks with global implications, highlighting the vulnerabilities of the continent's health systems.
Kesaobaka Batisani +1 more
wiley +1 more source
Strategies for the Modification of Vaccinia Virus towards a Better Vaccine Vector
ZoonosesVaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been extensively exploited as a preventive vaccine.
Hao Sun, Xinwen Chen, Yun Wang
doaj +1 more source
Smallpox and Bioterrorism: Why the Plan to Protect the Nation Is Stalled and What to Do [PDF]
, 2003 The Iraq war is over, no weapons of mass destruction (WMD) have yet been found, and the president's smallpox plan, though sound, is running out of steam. Instead of being well on the way to protecting the nation's civilian population by vaccinating up to
Kenneth D. Bloem, William J. Bicknell
core
Journal of Medical Virology, Volume 97, Issue 12, December 2025.ABSTRACT Ocular adverse events following COVID‐19 vaccination are well described; however, systematic analyses of non‐COVID antiviral vaccines remain limited. This review aimed to evaluate ocular complications associated with non‐COVID antiviral immunizations, including influenza, varicella‐zoster (VZV), human papillomavirus (HPV), and hepatitis B (HBV)
Yaru Zou +5 more
wiley +1 more source
The Effectiveness of California Assembly Bill 2109: Personal Belief Exemptions for Kindergarten Immunizations [PDF]
, 2016 The numbers of vaccine preventable diseases (VPDs) in the United States has declined with the development, administration, and effectiveness of vaccines during the 1970s and 1980s.
Goishi-Bessey, Lilli Shizuka
core +1 more source